Journals / İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi / 2014 / Cilt: 21 - Sayı: 2

Deneysel Diyabet Oluşturulan Sıçanlarda Meydana Gelen Karaciğer Hasarına Karşı Aminoguanidinin Antiapoptotik Etkileri

Anti-Apoptotic Effects of Aminoguanidine Against Liver Damage on Experimental Diabetes in Rats

Pages
111–117
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, it was found that the number of caspase-3 positive cells was significantly decreased in the STZ+AMG group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was designed to investigate the antiapoptotic and improving effects of aminoguanidine on the histological alterations in liver in streptozotocin (STZ)-induced diabetic rat model.
📊
Key Findings & Data:Material and Methods: 32 male Sprague Dawley rats were divided into the following 4 groups: Control, Aminoguanidine (AMG), Streptozotocin (STZ), Streptozotocin + Aminoguanidine (STZ+AMG).
💡
Conclusion & Impact:Moreover, it was found that the number of caspase-3 positive cells was significantly decreased in the STZ+AMG group.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was designed to investigate the antiapoptotic and improving effects of aminoguanidine on the histological alterations in liver in streptozotocin (STZ)-induced diabetic rat model. Material and Methods: 32 male Sprague Dawley rats were divided into the following 4 groups: Control, Aminoguanidine (AMG), Streptozotocin (STZ), Streptozotocin + Aminoguanidine (STZ+AMG). The animals in group STZ and STZ+AMG were made diabetic by intraperitoneal injection of streptozotocin 45 mg/kg. Histochemical and immunohistochemical staining methods were applied to sections obtained from paraffin blocks and preparations were examined by using Leica DFC-280 light microscope. Results: The sections taken from the control and AMG groups were normal in histological appearance. However, multifocal nodules containing inflammatory cells were observed in the diabetic group. Moreover necrotic hepatocytes and hemorrhagic areas were observed among intact hepatocyte of lobul in the STZ group. Glycogen loss was observed in the hepatocytes localized at the periphery of lobule. In addition, the numbers of cells with positive staining by caspase-3 were significantly increased. On the other hand, it was seen that, in the groups administered with STZ, histological injury in the liver was attenuated by the administration of AMG. Moreover, it was found that the number of caspase-3 positive cells was significantly decreased in the STZ+AMG group. Conclusion: We concluded that chronic aminoguanidine administration reduced liver injury in STZ- induced diabetic rats. Thus, we suggest that aminoguanidine may be used to prevent the development of diabetic liver damage

Özet

Amaç:Bu çalışma, streptozotosin (STZ) ile oluşturulan diyabetik sıçan modelinde, karaciğerde ortaya çıkan histolojik değişiklikler üzerine aminoguanidinin antiapoptotik ve iyileştirici etkilerinin araştırılması amacıyla planlandı. Gereç ve Yöntemler: Çalışmada 32 adet Sprague Dawley erkek sıçan kullanıldı. Sıçanlar her biri 8 adetten oluşan 4 gruba ayrıldı. Kontrol, aminoguanidin (AMG), Streptozosin (STZ), Streptozosin+AMG (STZ+AMG). Deneysel diyabet STZ ve STZ+AMG gruplarında tek doz STZ'nin (45 mg/kg) intraperitoneal (i.p.) uygulanması ile oluşturuldu. Alınan dokular, rutin doku takip işlemlerinden geçirilerek parafine gömüldü. Parafin bloklardan alınan kesitlere histokimyasal (Mayer's Hemotoksilen-Eozin, PAS) ve immunohistokimyasal (kaspaz-3) boyama yöntemleri uygulandı. Boyanan kesitler ve Leica DFC-280 ışık mikroskobunda incelendi. Bulgular: Kontrol ve AMG grubu normal histolojik görünümdeydi. Bununla birlikte STZ grubunda parankima içerisinde inflamatuvar hücre içeren multifokal nodüller izlendi. Ayrıca sağlam hepatositler arasında yerleşmiş asidofil sitoplazmalı ve heterokromatik nükleuslu nekrotik hücrelere ve hemorajik alanlara rastlandı. Lobülün periferinde yer alan hepatositlerde glikojen kaybı gözlendi. Ayrıca kaspaz-3 boyama metodu uygulanan kesitlerde kaspaz-3 (+) boyanan hücre sayılarının STZ grubunda, kontrol grubuna göre anlamlı derecede arttığı tespit edildi. STZ uygulanan sıçanlara AMG verilmesiyle karaciğerde izlenen histolojik hasarın düzeldiği izlendi. Ayrıca kaspaz-3 (+) hücre sayılarının azaldığı tespit edildi. Sonuç: Kronik aminoguanidin uygulaması, STZ ile sıçanlarda oluşturulan diyabetin neden olduğu karaciğer hasarını azalttı. Sonuç olarak aminoguanidinin diyabetik karaciğer hasarının gelişimini önleyeceğini düşünmekteyiz

🔖

Cite This Article

ELBE, H., VARDİ, N., TASLİDERE, E., ORMAN, D. (2022). Deneysel Diyabet Oluşturulan Sıçanlarda Meydana Gelen Karaciğer Hasarına Karşı Aminoguanidinin Antiapoptotik Etkileri. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, Cilt: 21 - Sayı: 2, 111–117. https://ajindex.com/articles/549396

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Altınova A, Aktürk M, Törüner F. Type I Diabetes mellitus and insulin resistance: review. Türkiye Klinikleri Tıp Bilimleri Dergisi 2007;27:406-12
  2. Schalkwıjk CG, Stehouwer CD. Vascular complications in diabetes mellitus: The role of endothelial dysfunction. Clin. Sci 2005;109:143.59
  3. Thang J, Kusaka I, Massey A, Rollıns S, Zhang J. Increased rhoA translocation in aorta of diabetic rats. Acta Pharmacol 2006;27:543.48
  4. Okyar A, Can A, Akev N, Baktır G, Sütlüpınar N. Effect of aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res 2001;15:157-61
  5. Covington DS, Xue H, Pizzini R, Lally KP, Andrassy RJ. Streptozotocin and alloxan are comparable agents in the diabetic model ofimpaired wound healing. Diabetes Res 1993; 23:47-53 6. Crouch RK, Gandy SE, Kimsey G, Galbraith RA, Galbraith GMC et. al. The inhibition of islet superoxide dismutase by diabetogenic drugs. Diabetes 1981;30:235- 41
  6. Sánchez SS, Abregú AV, Aybar MJ, Sánchez Riera AN. Changes in liver gangliosides in streptozotocin induced diabetic rats. Cell Biol Int 2000;24:897-904
  7. Memişoğulları R. Diyabette serbest radikallerin rolü ve antioksidanların etkisi. Düzce Tıp Fakültesi Dergisi 2005;3:30-39
  8. Bamri E. S, Ao ZJ, Londono I, Gingras D, Bendayan M. Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes. Lab Invest 2003;83:1069-80
  9. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997;45:50-56
  10. Giardino I, Fard AK, Hatchell DL, Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation and oxidant induced apoptosis. Diabetes 1998; 47:1114-20
  11. Al.Shabanah O, Alam K, Nagi MN. Al.Rikabi AC, Al.Bekairi AM. Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life. Sci 2000;66:265-70
  12. Pilkis SJ, Weber IT, Harrison RW, Bell GI. Glucokinase: structural analysis of a protein involved in susceptibility to diabetes. J Biol Chem 1994;269:219-25
  13. Sochor M, Baquer NZ, Hothersall JS, McLean P. Effect of experimental diabetes on the activity of hexokinase isoenzymes in tissues of the rat. Biochem Int 1990;22:467- 74
  14. Heineke EW, Johnson MB, Dillberger JE, Robinson KM. Antioxidant prevents diabetes in nonobese diabetic and multiple low dose STZ injected mice. Dia